Company: SLND-WT
Filing Date: 2025-05-20
Form Type: 424B3
Source: 0001829126-25-003846
Chunk: 8

Company: Southland Holdings, Inc.
Filing Date: 2025-05-20
Form: 424B3
Chunk 8
---
 Information.” Any of these risks could have a material adverse effect on our business, prospects, financial condition and results of operations. In any such case, the trading price of our securities could decline and you could lose all or part of your investment. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business operations.

Except as may be disclosed in any Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed after the date of this prospectus, there have been no material changes with respect to the risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2024.

<div align='center'>2

USE OF PROCEEDS</div>

All of the Common Stock offered by the Selling Stockholders pursuant to this prospectus will be sold by the Selling Stockholders for their respective accounts. We will not receive any of the proceeds from these sales.

The Selling Stockholders will pay any underwriting discounts and commissions and expenses incurred by the Selling Stockholders for brokerage, accounting, tax or legal services or any other expenses incurred by the Selling Stockholders in disposing of the securities. We will bear the costs, fees and expenses incurred in effecting the registration of the securities covered by this prospectus, including all registration and filing fees, NYSE listing fees and fees and expenses of our counsel and our independent registered public accounting firm.

<div align='center'>3

SELLING STOCKHOLDERS</div>

This prospectus relates to the offer and sale from time to time by the Selling Stockholders (including their pledgees, donees, transferees, assignees, successors and other permitted transferees) of up to 5,942,233 shares of Common Stock, consisting of up to (i) 3,396,233 shares of Common Stock issued to Frank S. Renda in the Private Placement; (ii) 2,215,664 shares of Common Stock issued to Rudy V. Renda in the Private Placement; (iii) 219,002 shares of Common Stock issued to Tim Winn in the Private Placement; and (iv) 111,334 shares of Common Stock issued to Cody Gallarda upon the vesting of certain Restricted Stock Units (“RSUs”). When we refer to the “Selling Stockholders” in this prospectus, we refer to the persons listed in the table below, and the pledgees, donees, transferees, assignees, successors and other permitted transfere